Refine Results
  1. "Lymphoma"
Formats
  1. Meeting Abstract (968)
  2. Journal Article (891)
  3. Book Section (62)
  4. Conference Paper (12)
  5. Editorial (10)
  6. Research Letter (7)
  7. Review (6)
  8. Book Whole (4)
  9. Miscellaneous (3)
  10. Guidelines (2)
Groups
  1. Center for Hematologic Malignancies (1965)
  2. Lymphoma (1965)
  3. Hematologic Malignancies, Division of (1021)
  4. Hematologic Oncology, Division of (944)
  5. Population Sciences Research Program (628)
  6. Survivorship Research (403)

More Groups

People
  1. Andrew Zelenetz (639)
  2. Steven Horwitz (465)
  3. Anas Younes (286)
  4. David Straus (286)
  5. Ariela Noy (269)
  6. Craig Moskowitz (263)

More People

Years
  1. 2021 (22)
  2. 2020 (134)
  3. 2019 (223)
  4. 2018 (141)
  5. 2017 (162)
  6. 2016 (148)

More Years

Publications
  1. Blood (596)
  2. Journal of Clinical Oncology (228)
  3. Hematological Oncology (67)
  4. Leukemia and Lymphoma (63)
  5. British Journal of Haematology (59)
  6. Annals of Oncology (53)

More Publications

Publishers
  1. American Society of Hematology (620)
  2. American Society of Clinical Oncology (243)
  3. Elsevier Inc. (128)
  4. Wiley Blackwell (120)
  5. Nature Publishing Group (79)
  6. John Wiley & Sons (75)

More Publishers

Results (1965)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): A double-blind, randomised, placebo-controlled, phase 3 trial
    Journal Article

    Matasar, M. J.; Capra, M.; Özcan, M.; Lv, F.; Li, W.; Yañez, E.; Sapunarova, K.; Lin, T.; Jin, J.; Jurczak, W; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Noninvasive monitoring of mantle cell lymphoma by immunoglobulin gene next-generation sequencing in a phase 2 study of sequential chemoradioimmunotherapy followed by autologous stem-cell rescue
    Journal Article

    Kumar, A.; Bantilan, K. S.; Jacob, A. P.; Park, A.; Schoninger, S. F.; Sauter, C.; Ulaner, G. A.; Casulo, C.; Faham, M.; Kong, K. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway
    Journal Article

    Quesada, A. E.; Zhang, Y.; Ptashkin, R.; Ho, C.; Horwitz, S.; Benayed, R.; Dogan, A.; Arcila, M. E.
    Breast Journal (2021)

    Fulltext@MSK | Save
  • Discovery of protein modifications using differential tandem mass spectrometry proteomics
    Journal Article

    Cifani, P.; Li, Z.; Luo, D.; Grivainis, M.; Intlekofer, A. M.; Fenyö, D.; Kentsis, A.
    Journal of Proteome Research (2021)

    Fulltext@MSK | Save
  • Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis
    Journal Article

    Kim, Y. H.; Prince, H. M.; Whittaker, S.; Horwitz, S. M.; Duvic, M.; Bechter, O.; Sanches, J. A.; Stadler, R.; Scarisbrick, J.; Quaglino, P.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition
    Journal Article

    Bala Tannan, N.; Manzari, M. T.; Herviou, L.; Da Silva Ferreira, M.; Hagen, C.; Kiguchi, H.; Manova-Todorova, K.; Seshan, V.; de Stanchina, E.; Heller, D. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in human immunodeficiency virus-associated, B-cell non-Hodgkin lymphoma
    Journal Article

    Sparano, J. A.; Lee, J. Y.; Kaplan, L. D.; Ramos, J. C.; Ambinder, R. F.; Wachsman, W.; Aboulafia, D.; Noy, A.; Henry, D. H.; Ratner, L.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Quality of life effect of the anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat in patients with cutaneous T-cell lymphoma
    Journal Article

    Porcu, P.; Hudgens, S.; Horwitz, S.; Quaglino, P.; Cowan, R.; Geskin, L.; Beylot-Barry, M.; Floden, L.; Bagot, M.; Tsianakas, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • The International Prognostic Index is associated with outcomes in diffuse large B cell lymphoma after chimeric antigen receptor T cell therapy
    Journal Article

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Shouval, R.; Afuye, A. O.; Silverberg, M. L.; Batlevi, C. W.; Dahi, P.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Oncologic immunomodulatory agents in patients with cancer and COVID-19
    Journal Article

    Jee, J.; Stonestrom, A. J.; Devlin, S.; Nguyentran, T.; Wills, B.; Narendra, V.; Foote, M. B.; Lumish, M.; Vardhana, S. A.; Pastores, S. M.; more...
    Scientific Reports (2021)

    Fulltext@MSK | Save